Document is current
Any future updates will be listed below
-
Authors
Secco, Ilaria https://orcid.org/0000-0002-3920-7565
Backovic, Ana
Tomczyk, Mateusz https://orcid.org/0000-0001-9322-748X
Mura, Antonio
Li, Gang
Bortolotti, Francesca
Vodret, Simone
Dal Ferro, Matteo
Chiavacci, Elena https://orcid.org/0000-0003-3924-3635
Zentilin, Lorena
Sinagra, Gianfranco
Zacchigna, Serena https://orcid.org/0000-0001-6705-3076
Mano, Miguel https://orcid.org/0000-0003-1922-4824
Giacca, Mauro https://orcid.org/0000-0003-2927-7225
- License Information
-
More Information
Article History
Received: 24 April 2024
Accepted: 6 February 2025
First Online: 7 March 2025
Competing interests
: M.G. is the scientific founder, consultant, member of the Board, and equity holder in Forcefield Therapeutics and Heqet Therapeutics and founder and equity holder of Purespring Therapeutics. The remaining authors declare no competing interests.
